The MCO-010 vector uses surviving cells in the retina to produce a photosensitive protein that may help patients regain some ...

Cirrus Therapeutics secured an $11 million seed financing led by ClavystBio. Polaris Partners and SEEDS also joined in the ...

Cirrus’ lead program is a novel AAV gene therapy designed to restore IRAK-M, a central regulator of the eye’s immune homeostasis, so as to ...

Universities must do more to provide students with cell and gene therapy manufacturing skills, according to a new study.

A free research study at Nebraska Medicine is offering you the chance to learn how your genetics could impact your health.

Biologics are drugs that require a living organism to manufacture, instead of simply being compounded in a lab. Read on to ...

Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase III IMforte ...

These industry and investor meetings provide an excellent forum to share specifically how Ocugen is advancing toward our goal of three BLAs in the next three years,” said Dr. Shankar Musunuri, ...

With layoffs happening at biopharma companies of all sizes, some may wonder which jobs are safest. Talent acquisition experts ...

As September concludes, the landscape of hematologic oncology continues to evolve, spanning the full spectrum of blood cancer ...

Relive Health, one of the nation’s fastest-growing providers of integrative and regenerative care, has partnered with Dr.